UMB Bank’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.41K | Hold |
350
| – | – | ﹤0.01% | 1803 |
|
|
2025
Q1 | $5.21K | Hold |
350
| – | – | ﹤0.01% | 1748 |
|
|
2024
Q4 | $4.63K | Buy |
350
+124
| +55% | +$1.64K | ﹤0.01% | 1730 |
|
|
2024
Q3 | $3.21K | Sell |
226
-41
| -15% | -$583 | ﹤0.01% | 1854 |
|
|
2024
Q2 | $3.46K | Sell |
267
-267
| -50% | -$3.46K | ﹤0.01% | 1570 |
|
|
2024
Q1 | $7.42K | Hold |
534
| – | – | ﹤0.01% | 1329 |
|
|
2023
Q4 | $7.62K | Sell |
534
-990
| -65% | -$14.1K | ﹤0.01% | 1354 |
|
|
2023
Q3 | $23.6K | Sell |
1,524
-1,200
| -44% | -$18.6K | ﹤0.01% | 1036 |
|
|
2023
Q2 | $42.8K | Hold |
2,724
| – | – | ﹤0.01% | 880 |
|
|
2023
Q1 | $44.9K | Buy |
2,724
+1,306
| +92% | +$21.5K | ﹤0.01% | 863 |
|
|
2022
Q4 | $22K | Sell |
1,418
-1,477
| -51% | -$22.9K | ﹤0.01% | 1090 |
|
|
2022
Q3 | $37K | Sell |
2,895
-1,611
| -36% | -$20.6K | ﹤0.01% | 946 |
|
|
2022
Q2 | $64K | Sell |
4,506
-614
| -12% | -$8.72K | ﹤0.01% | 847 |
|
|
2022
Q1 | $74K | Buy |
5,120
+370
| +8% | +$5.35K | ﹤0.01% | 851 |
|
|
2021
Q4 | $65K | Buy |
+4,750
| New | +$65K | ﹤0.01% | 915 |
|